RNU6-1334P

Across TCGA pan-cancer cohorts, RNU6-1334P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-1334P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNU6-1334P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1334P expression acts as an unfavorable survival marker, although some lineages such as PAAD and ACC show a favorable association.

COAD, LIHC, and SKCM are the cancer types where RNU6-1334P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.173	0.617	<.001	144	view →
LIHC	OS	Tertile	III,IV	0.092	0.649	<.001	54	view →
SKCM	DFS	Tertile	III,IV	0.170	0.620	<.001	45	view →
PAAD	DFS	Tertile	All	0.795	0.256	.008	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
LGG	OS	Tertile	All	0.480	0.827	<.001	36	view →
THCA	DFS	Tertile	All	0.161	0.829	.007	27	view →
GBM	OS	Tertile	All	0.076	0.415	<.001	18	view →
STAD	DFS	Tertile	All	0.473	0.667	.016	18	view →
PRAD	OS	Tertile	All	0.953	0.995	.010	12	view →
ACC	DFS	Tertile	III,IV	1.000	0.405	.045	12	view →
KIRC	OS	Tertile	All	0.675	0.812	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-1334P–COAD (OS)

Open the COAD breakdown →